EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: person:"Shavit, Oren"
Narrow search

Narrow search

Year of publication
Subject
All
Clinical-trial-design 2 Cost-effectiveness 2 Arzneimittel 1 Arzneimittelmarkt 1 Cervical-cancer 1 Cervical-intraepithelial-neoplasia 1 Cost-benefit 1 Cost-of-illness 1 Droge 1 Drogenkonsum 1 Drug 1 Drug consumption 1 Drug price 1 Drug reimbursement 1 Genital-warts 1 Gesundheitskosten 1 Gesundheitswesen 1 Health care costs 1 Health care system 1 Healthcare expenditure 1 Human-papillomavirus-infections 1 Pharmaceutical industry 1 Pharmaceutical market 1 Pharmaceuticals 1 Pharmaindustrie 1 Preis 1 Preismanagement 1 Preisregulierung 1 Price 1 Price regulation 1 Pricing strategy 1 Value-based pricing 1 Value-of-information-analysis 1
more ... less ...
Online availability
All
Undetermined 7
Type of publication
All
Article 7
Type of publication (narrower categories)
All
Article in journal 1 Aufsatz in Zeitschrift 1
Language
All
Undetermined 6 English 1
Author
All
Shavit, Oren 7 Goldberger, Assaf 3 Hoffman, Amnon 3 Leshno, Moshe 3 Shmueli, Amir 3 Arbel, Daphna 2 Ben-David, Yehuda 2 Chodick, Gabriel 2 Cohen, Raanan 2 Raz, Raanan 2 Schejter, Eduardo 2 Shalev, Varda 2 Stein, Michal 2 Ben-Aharon, Omer 1 Magnezi, Racheli 1
more ... less ...
Published in...
All
PharmacoEconomics 3 Applied Health Economics and Health Policy 2 Health Policy 1 The European journal of health economics : HEPAC ; health economics in prevention and care 1
Source
All
RePEc 6 ECONIS (ZBW) 1
Showing 1 - 7 of 7
Cover Image
Does drug price-regulation affect healthcare expenditures?
Ben-Aharon, Omer; Shavit, Oren; Magnezi, Racheli - In: The European journal of health economics : HEPAC ; … 18 (2017) 7, pp. 859-867
Persistent link: https://www.econbiz.de/10011869108
Saved in:
Cover Image
Evaluating the Epidemiology and Morbidity Burden Associated with Human Papillomavirus in Israel: Accounting for CIN1 and Genital Warts in Addition to CIN2/3 and Cervical Cancer
Shavit, Oren; Raz, Raanan; Stein, Michal; Chodick, Gabriel - In: Applied Health Economics and Health Policy 10 (2012) 2, pp. 87-97
Background:Background: Human papillomavirus (HPV) infection is mostly associated with cervical cancer (CC). However, it can cause other illnesses as well, all of which impact on people's wellbeing and consume healthcare resources. Measures for prevention or early detection of these conditions...
Persistent link: https://www.econbiz.de/10009647783
Saved in:
Cover Image
Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel
Shavit, Oren; Raz, Raanan; Stein, Michal; Chodick, Gabriel - In: Applied Health Economics and Health Policy 10 (2012) 2, pp. 87-97
HPV poses a significant burden in terms of health (clinical and quality of life) and in monetary terms, even for conditions that are sometimes regarded as benign, such as CIN1 or genital warts. Current findings should be used for proper evaluation of measures to reduce HPV-related morbidity and...
Persistent link: https://www.econbiz.de/10011000866
Saved in:
Cover Image
Utilization of health technologies--Do not look where there is a light; shine your light where there is a need to look!: Relating national health goals with resource allocation decision-making; illustration through examining the Israeli healthcare system
Shavit, Oren - In: Health Policy 92 (2009) 2-3, pp. 268-275
Innovative health technologies are often the focus of attention. However, in the allocation of public resources for improving health, the focus should be on the health needs of the population. It is the need that should be analyzed first, and decision makers should then evaluate the full range...
Persistent link: https://www.econbiz.de/10005077615
Saved in:
Cover Image
The Authors
Shavit, Oren; Leshno, Moshe; Goldberger, Assaf; … - In: PharmacoEconomics 26 (2008) 10, pp. 892-894
DOI: 10.2165/0019053-200826100-00009
Persistent link: https://www.econbiz.de/10004997788
Saved in:
Cover Image
It's Time to Choose the Study Design!: Net Benefit Analysis of Alternative Study Designs to Acquire Information for Evaluation of Health Technologies
Shavit, Oren; Leshno, Moshe; Goldberger, Assaf; … - In: PharmacoEconomics 25 (2007) 11, pp. 903-911
Uncertainty in the decision-making process for reimbursement of health technologies could be reduced if additional information were available. Although methods to evaluate the monetary value of the uncertainty have been previously described, an economic evaluation of alternative methods to...
Persistent link: https://www.econbiz.de/10005590472
Saved in:
Cover Image
It’s Time to Choose the Study Design!
Shavit, Oren; Leshno, Moshe; Goldberger, Assaf; … - In: PharmacoEconomics 25 (2007) 11, pp. 903-911
Uncertainty in the decision-making process for reimbursement of health technologies could be reduced if additional information were available. Although methods to evaluate the monetary value of the uncertainty have been previously described, an economic evaluation of alternative methods to...
Persistent link: https://www.econbiz.de/10010634516
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...